Cancers | Highly Cited Special Issues in 2024 in the “Cancer Drug Development” Section
27 July 2025
We are delighted to share some highly cited Special Issues in 2024 in the “Cancer Drug Development” Section in Cancers (ISSN: 2072-6694).
The list of highly cited Special Issues can be viewed below:
| “Anticancer Drug Discovery Based on Natural Products: From Computational Approaches to Clinical Studies” Guest Editors: Dr. Rajeev K. Singla and Prof. Dr. Anupam Bishayee Viewed by: 38340+ |
“The Roles of microRNAs in Cancer Aggressiveness and Drug Resistance, Volume II” Guest Editors: Dr. Bi-Dar Wang and Prof. Dr. Luciane R Cavalli Viewed by: 12750+ |
 |
 |
| “Tissue Agnostic Drug Development in Cancer” Guest Editors: Dr. Shivaani Kummar and Dr. Kyaw Thein Viewed by: 19600+ |
“Molecular Mechanisms of Anti-Cancer Drugs Action” Guest Editor: Dr. Barbara Pucelik Viewed by: 14580+ |
 |
 |
| “Cancer Cell Metabolism and Drug Targets” Guest Editors: Dr. Daniel S. Sitar and Prof. Dr. Donald Miller Viewed by: 15170+ |
“Melatonin and Cancer: Current Challenges and Future Perspectives” Guest Editors: Dr. Francisco López-Muñoz and Prof. Dr. Alejandro Romero Martínez Viewed by: 12540+ |
 |
 |
We invite you to read and submit relevant papers to the journal Cancers using the following link:
https://www.mdpi.com/journal/cancers.
Cancers Editorial Office